APA (7th ed.) Citation

GA, L., WL, L., DP, K., YT, L., YW, C., YC, C., . . . CY, C. (2021). Detection of PD-L1 Expression in Temozolomide-Resistant Glioblastoma by Using PD-L1 Antibodies Conjugated with Lipid‑Coated Superparamagnetic Iron Oxide. International journal of nanomedicine, 16, 5233. https://doi.org/10.2147/IJN.S310464

Chicago Style (17th ed.) Citation

GA, Lee, Lin WL, Kuo DP, Li YT, Chang YW, Chen YC, Huang SW, Hsu JB, and Chen CY. "Detection of PD-L1 Expression in Temozolomide-Resistant Glioblastoma by Using PD-L1 Antibodies Conjugated with Lipid‑Coated Superparamagnetic Iron Oxide." International Journal of Nanomedicine 16 (2021): 5233. https://doi.org/10.2147/IJN.S310464.

MLA (9th ed.) Citation

GA, Lee, et al. "Detection of PD-L1 Expression in Temozolomide-Resistant Glioblastoma by Using PD-L1 Antibodies Conjugated with Lipid‑Coated Superparamagnetic Iron Oxide." International Journal of Nanomedicine, vol. 16, 2021, p. 5233, https://doi.org/10.2147/IJN.S310464.